Computer-aided discovery of potential inhibitors for transthyretin-related amyloidosis

Zheng Li Zhou, Hsuan Liang Liu, Josephine W. Wu, Cheng Wen Tsao, Wei Hsi Chen, Kung Tien Liu, Yih Ho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Transthyretin (TTR) is a homotetrameric plasma protein associated with human amyloid diseases. Although Tafamidis has been recently approved for the treatment of TTR familial amyloid polyneuropathy (FAP), there is still a need for more effective drugs in the treatment of TTR amyloidosis diseases. In this study, a computer-aided approach combining molecular docking, virtual screening and molecular dynamics (MD) simulations was employed to identify potent TTR amyloidosis inhibitors from National Cancer Institute (NCI), Maybridge and Asdi databases. A receptor-specific scoring function was also developed using comparative binding energy (COMBINE) method to accurately predict the inhibitory activities for the selected compounds during virtual screening. The developed receptor-specific scoring function demonstrated good predictive ability by yielding strong correlation coefficients between experimental activities and estimated activities for 32 training set and 9 test set compounds, respectively. Moreover, it was successfully applied to rank the candidate compounds from structure-based virtual screening. Finally, three compounds (NSC220163, MFCD00276817 and SPB06319) were identified as potential leads, which exhibited higher predicted inhibitory activities and higher binding affinities in comparison to the Tafamidis. Our results further suggest that halogen bonding interaction plays a crucial role in stabilizing the TTR-inhibitor complex. These results indicate that our computational approach could effectively discover more potent TTR amyloidosis inhibitors, which can be further validate by in vitro and in vivo biological tests. In this study, we combined the molecular docking, receptor-specific scoring function, virtual screening and molecular dynamics (MD) simulations to search potent TTR amyloidosis inhibitors from NCI, Maybridge and Asdi databases. Finally, only three compounds were identified as potential hits.

Original languageEnglish
Pages (from-to)263-273
Number of pages11
JournalJournal of the Chinese Chemical Society
Volume61
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Prealbumin
Screening
Amyloid
Molecular dynamics
Halogens
Computer simulation
Binding energy
Blood Proteins
Pharmaceutical Preparations

Keywords

  • Amyloid diseases
  • Halogen bond
  • Molecular dynamics simulations
  • Receptor-specific scoring function
  • Structure-based virtual screening
  • Transthyretin

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Computer-aided discovery of potential inhibitors for transthyretin-related amyloidosis. / Zhou, Zheng Li; Liu, Hsuan Liang; Wu, Josephine W.; Tsao, Cheng Wen; Chen, Wei Hsi; Liu, Kung Tien; Ho, Yih.

In: Journal of the Chinese Chemical Society, Vol. 61, No. 2, 2014, p. 263-273.

Research output: Contribution to journalArticle

Zhou, Zheng Li ; Liu, Hsuan Liang ; Wu, Josephine W. ; Tsao, Cheng Wen ; Chen, Wei Hsi ; Liu, Kung Tien ; Ho, Yih. / Computer-aided discovery of potential inhibitors for transthyretin-related amyloidosis. In: Journal of the Chinese Chemical Society. 2014 ; Vol. 61, No. 2. pp. 263-273.
@article{e572e18b42dc42adb9c072cab8f23a8c,
title = "Computer-aided discovery of potential inhibitors for transthyretin-related amyloidosis",
abstract = "Transthyretin (TTR) is a homotetrameric plasma protein associated with human amyloid diseases. Although Tafamidis has been recently approved for the treatment of TTR familial amyloid polyneuropathy (FAP), there is still a need for more effective drugs in the treatment of TTR amyloidosis diseases. In this study, a computer-aided approach combining molecular docking, virtual screening and molecular dynamics (MD) simulations was employed to identify potent TTR amyloidosis inhibitors from National Cancer Institute (NCI), Maybridge and Asdi databases. A receptor-specific scoring function was also developed using comparative binding energy (COMBINE) method to accurately predict the inhibitory activities for the selected compounds during virtual screening. The developed receptor-specific scoring function demonstrated good predictive ability by yielding strong correlation coefficients between experimental activities and estimated activities for 32 training set and 9 test set compounds, respectively. Moreover, it was successfully applied to rank the candidate compounds from structure-based virtual screening. Finally, three compounds (NSC220163, MFCD00276817 and SPB06319) were identified as potential leads, which exhibited higher predicted inhibitory activities and higher binding affinities in comparison to the Tafamidis. Our results further suggest that halogen bonding interaction plays a crucial role in stabilizing the TTR-inhibitor complex. These results indicate that our computational approach could effectively discover more potent TTR amyloidosis inhibitors, which can be further validate by in vitro and in vivo biological tests. In this study, we combined the molecular docking, receptor-specific scoring function, virtual screening and molecular dynamics (MD) simulations to search potent TTR amyloidosis inhibitors from NCI, Maybridge and Asdi databases. Finally, only three compounds were identified as potential hits.",
keywords = "Amyloid diseases, Halogen bond, Molecular dynamics simulations, Receptor-specific scoring function, Structure-based virtual screening, Transthyretin",
author = "Zhou, {Zheng Li} and Liu, {Hsuan Liang} and Wu, {Josephine W.} and Tsao, {Cheng Wen} and Chen, {Wei Hsi} and Liu, {Kung Tien} and Yih Ho",
year = "2014",
doi = "10.1002/jccs.201300172",
language = "English",
volume = "61",
pages = "263--273",
journal = "Journal of the Chinese Chemical Society",
issn = "0009-4536",
publisher = "Chinese Chemical Society",
number = "2",

}

TY - JOUR

T1 - Computer-aided discovery of potential inhibitors for transthyretin-related amyloidosis

AU - Zhou, Zheng Li

AU - Liu, Hsuan Liang

AU - Wu, Josephine W.

AU - Tsao, Cheng Wen

AU - Chen, Wei Hsi

AU - Liu, Kung Tien

AU - Ho, Yih

PY - 2014

Y1 - 2014

N2 - Transthyretin (TTR) is a homotetrameric plasma protein associated with human amyloid diseases. Although Tafamidis has been recently approved for the treatment of TTR familial amyloid polyneuropathy (FAP), there is still a need for more effective drugs in the treatment of TTR amyloidosis diseases. In this study, a computer-aided approach combining molecular docking, virtual screening and molecular dynamics (MD) simulations was employed to identify potent TTR amyloidosis inhibitors from National Cancer Institute (NCI), Maybridge and Asdi databases. A receptor-specific scoring function was also developed using comparative binding energy (COMBINE) method to accurately predict the inhibitory activities for the selected compounds during virtual screening. The developed receptor-specific scoring function demonstrated good predictive ability by yielding strong correlation coefficients between experimental activities and estimated activities for 32 training set and 9 test set compounds, respectively. Moreover, it was successfully applied to rank the candidate compounds from structure-based virtual screening. Finally, three compounds (NSC220163, MFCD00276817 and SPB06319) were identified as potential leads, which exhibited higher predicted inhibitory activities and higher binding affinities in comparison to the Tafamidis. Our results further suggest that halogen bonding interaction plays a crucial role in stabilizing the TTR-inhibitor complex. These results indicate that our computational approach could effectively discover more potent TTR amyloidosis inhibitors, which can be further validate by in vitro and in vivo biological tests. In this study, we combined the molecular docking, receptor-specific scoring function, virtual screening and molecular dynamics (MD) simulations to search potent TTR amyloidosis inhibitors from NCI, Maybridge and Asdi databases. Finally, only three compounds were identified as potential hits.

AB - Transthyretin (TTR) is a homotetrameric plasma protein associated with human amyloid diseases. Although Tafamidis has been recently approved for the treatment of TTR familial amyloid polyneuropathy (FAP), there is still a need for more effective drugs in the treatment of TTR amyloidosis diseases. In this study, a computer-aided approach combining molecular docking, virtual screening and molecular dynamics (MD) simulations was employed to identify potent TTR amyloidosis inhibitors from National Cancer Institute (NCI), Maybridge and Asdi databases. A receptor-specific scoring function was also developed using comparative binding energy (COMBINE) method to accurately predict the inhibitory activities for the selected compounds during virtual screening. The developed receptor-specific scoring function demonstrated good predictive ability by yielding strong correlation coefficients between experimental activities and estimated activities for 32 training set and 9 test set compounds, respectively. Moreover, it was successfully applied to rank the candidate compounds from structure-based virtual screening. Finally, three compounds (NSC220163, MFCD00276817 and SPB06319) were identified as potential leads, which exhibited higher predicted inhibitory activities and higher binding affinities in comparison to the Tafamidis. Our results further suggest that halogen bonding interaction plays a crucial role in stabilizing the TTR-inhibitor complex. These results indicate that our computational approach could effectively discover more potent TTR amyloidosis inhibitors, which can be further validate by in vitro and in vivo biological tests. In this study, we combined the molecular docking, receptor-specific scoring function, virtual screening and molecular dynamics (MD) simulations to search potent TTR amyloidosis inhibitors from NCI, Maybridge and Asdi databases. Finally, only three compounds were identified as potential hits.

KW - Amyloid diseases

KW - Halogen bond

KW - Molecular dynamics simulations

KW - Receptor-specific scoring function

KW - Structure-based virtual screening

KW - Transthyretin

UR - http://www.scopus.com/inward/record.url?scp=84898623962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898623962&partnerID=8YFLogxK

U2 - 10.1002/jccs.201300172

DO - 10.1002/jccs.201300172

M3 - Article

AN - SCOPUS:84898623962

VL - 61

SP - 263

EP - 273

JO - Journal of the Chinese Chemical Society

JF - Journal of the Chinese Chemical Society

SN - 0009-4536

IS - 2

ER -